The Natural History of Familial Dysautonomia
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT03920774
- Status
- Recruiting
Conditions
- Familial Dysautonomia (Riley-Day Syndrome)
- Hereditary Sensory and Autonomic Neuropathies
- Hereditary Sensory and Autonomic Neuropathy 3
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment. This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study will document the clinical features of patients with FD overtime by storing their routine clinical test results in a central database. The study will involve collaborators at other specialist clinics around the world who follow/evaluate patients with FD annually. Providing blood for future use is optional.
Key Dates
- First listed
- Apr 19, 2019
- Start date
- Feb 22, 2017
- Status verified
- Nov 2025
- Primary completion
- Feb 21, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Familial DysautonomiaPatients diagnosed with familial dysautonomia, a genetic disorder that affects the development and survival of nerve cells in the autonomic nervous system. It primarily affects neurons that control involuntary actions like regulation of blood pressure and breathing. It also affects the sensory nervous system and the perception of pain, heat and cold.
Primary Outcome Measure
1. To create a database of familial dysautonomia disorder that will serve as a phenotypic core [ Time Frame: 5 years ]
Central Contacts
- Britney A. Paredes Lopez2122637225
- Horacio Kaufmann, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dysautonomia Center - School of Medicine -NYU Langone Medical Center | New York | New York | 10016 | Horacio Kaufmann, MD Horacio Kaufmann, MD (PRINCIPAL_INVESTIGATOR) |